Maine officials confirm first Powassan virus death of 2023

Officials in Maine have confirmed the first fatal case of the Powassan virus disease in 2023. The Maine Center for Disease Control said Wednesday they found the tick-borne illness in an adult resident from Sagadahoc County.

More News

Ocaliva for NASH Gets Thumbs Down From FDA Advisors

On Friday, the Gastrointestinal Drugs Advisory Committee voted 12-2 (with two abstentions) that the improvements in liver scarring seen in the pivotal REGENERATE trial with a 25-mg dose of obeticholic acid do not outweigh the various risks,

Contaminated eyedrops now linked to 4 deaths, 14 cases of blindness: CDC

Eye drops that have been contaminated with a highly drug-resistant strain of bacteria have now been linked to four deaths and 14 cases of blindness, according to an update from the Centers for

'Staggering' Weight Loss and Benefits in Body Composition With Tirzepatide

Over 60% of participants achieved the weight-reduction target of 20% or higher and had improved body composition in a phase 3 trial of tirzepatide in overweight/obesity.

Major League Baseball launches 'MLB Together' community assistance platform

Major League Baseball launched a community assistance platform Wednesday called “MLB Together.” The platform will focus on youth empowerment; diversity, equity and inclusion; domestic and physical safety;

Best Hospitals for Back Surgery (Spinal Fusion) in Phoenix, AZ

Search hospitals in Phoenix, AZ that treat Back Surgery (Spinal Fusion) to find the best hospital for you.

Excess weight in teens, 20s may raise risk of fatal prostate cancer later

When young men pack on excess weight during their teens and 20s, they may inadvertently drive up their risk for prostate cancer later on.

30% of Adults Depressed; Safety Anxiety Runs High; Reimbursement Woes for ADHD Games

Nearly 30% of U.S. adults say they've been diagnosed with depression at some point in their lives -- up 10% since 2015 -- according to a Gallup poll. The FDA issued updated warnings to improve safe use of prescription stimulants to treat attention deficit-hyperactivity disorder (ADHD) and other conditions.

.

.